


| Key | % Net Assets |
|---|---|
| 7.7% | |
| 7.3% | |
| 6.8% | |
| 6.7% | |
| 71.5% |
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline | 7.7% |
| HSBC Holdings PLC (UK Reg) | 7.3% |
| Astrazeneca | 6.8% |
| BG GROUP | 6.7% |
| UNILEVER | 5.0% |
| ROYAL DUTCH SHELL B | 4.1% |
| Booker Group | 3.9% |
| William Morrison Supermarkets | 3.4% |
| Compass Group | 3.0% |
| Centrica | 2.9% |
No asset data available.
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 01/09/1968 |
|---|---|
| Fund Manager | Richard Colwell |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | 1000 |
| Additional | n/a |
| Savings | 50 |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.10 |
You are here: research